1. Home
  2. Live Updates
  3. Late breaking

Live Breaking News & Updates on Late breaking

Stay informed with the latest breaking news from Late breaking on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Late breaking and stay connected to the pulse of your community

VYNE Therapeutics Announces Oral Presentations for VYN201 at the 2024 Society for Investigative Dermatology (SID) Annual Meeting

VYNE Therapeutics Announces Oral Presentations for VYN201 at the 2024 Society for Investigative Dermatology (SID) Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Dallas , Texas , Iain-stuart , John-fraunces , Tyler-zeronda , Meeting-of-the-society-for-investigative-dermatology , Tay-therapeutics , Nasdaq , Therapeutics-inc , Exchange-commission , Lifesci-advisors

Castin' 'n Catchin' fundraiser kicks off in North Alabama

Hundreds of anglers participated in the Castin' 'n Catchin' tournament in Scottsboro, Alabama, with the aim of raising funds for children suffering from heart issues.

Alabama , United-states , Scottsboro , Jason-simpson , Patsy-douglas , Children-of-alabama-heart-center , Children-of-alabama-heart-center-simpson , Alabama-heart-center-simpson , Alabama-heart-center , Alabama-heart , Late-breaking , Ish

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024…

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024…
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Cytokinetics-incorporated , Primary-results , Positive-topline-results , Obstructive-hypertrophic , Additional-analyses , Exercise-capacity , Late-breaking ,

Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy

SEATTLE--(BUSINESS WIRE)--Apr 10, 2024--

United-states , Argentina , Buenos-aires , Distrito-federal , James-tumlin , Nasdaq , Linkedin , Alpine-immune-sciences , Nephronet-clinical-trials-consortium , Buenos-aires-convention-center , Exchange-commission , Securities-exchange

INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO

ROOT, Switzerland--(BUSINESS WIRE)--Mar 11, 2024--

United-states , Israel , Luxembourg , Switzerland , Belgium , New-hampshire , Leuven , Region-flamande , Tokyo , Japan , Barcelona , Comunidad-autonoma-de-cataluna

Discussing New Phase 2 Findings on Lutikizumab for Hidradenitis Suppurativa with Alexa Kimball, MD, MPH

Kimball discusses her team’s new late-breaking data regarding the safety and effectiveness of lutikizumab in treating the symptoms of moderate-to-severe HS in adult non-responders to anti-TNF therapy.


Massachusetts , United-states , American , Alexa-kimball , Harvard-medical-school , American-academy-of-dermatology , Annual-meeting , Hidradenitis-suppurativa-clinical-response , Massachusetts-general-hospital , Numeric-rating-scale , Global-assessment , Hs

AlzeCure Pharma: AlzeCure Gets Late Breaking Abstract of New Preclinical Data with ACD856 Accepted at AD/PD 2024 Conference

AlzeCure Pharma: AlzeCure Gets Late Breaking Abstract of New Preclinical Data with ACD856 Accepted at AD/PD 2024 Conference
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Sweden , Lisbon , Lisboa , Portugal , Stockholm , Swedish , Alzecure-pharma , Stefan-klotter , Gunnar-nordvall , Johan-sandin , Veronica-lidell , Dr-alzecure-pharma

Afimetoran Shown to be Safe, Well-Tolerated for Patients with Cutaneous Lupus Erythematosus

This new late-breaking data presented at ACR 2023 was the first clinical evidence indicating efficacy of afimetoran for those with CLE.


California , United-states , San-diego , Fareeda-hosein , Bristol-myers-squibb , American-college-of-rheumatology , American-college , Bristol-myers , Severity-index-activity , Late-breaking , Cutaneous-lupus , Afimetoran

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs

Temple-university , Pennsylvania , United-states , Philadelphia , America , American , Corey-davis , Veronica-eames , Mark-sulkowski , Exchange-commission-on , Temple-university-school-of-medicine , American-association-of-liver-disease-on

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Philadelphia , Pennsylvania , Temple-university , America , American , Veronica-eames , Mark-sulkowski , Corey-davis , American-association-of-liver-disease-on , American-society-for-clinical-investigation , Lifesci-communications